Early Erythropoietin Administration does not Increase the Risk of Retinopathy in Preterm Infants
Open Access
- 23 June 2016
- journal article
- research article
- Published by Elsevier BV in Pediatrics & Neonatology
- Vol. 58 (1), 48-56
- https://doi.org/10.1016/j.pedneo.2016.03.006
Abstract
No abstract availableKeywords
Funding Information
- China Medical University Hospital (DMR100-056)
This publication has 34 references indexed in Scilit:
- Management of retinopathy of prematurityArchives of Disease in Childhood: Fetal & Neonatal, 2013
- Endogenous Erythropoietin Protects Neuroretinal Function in Ischemic RetinopathyThe American Journal of Pathology, 2012
- Retinopathy of prematurity: A study of prevalence and risk factorsMiddle East African Journal of Ophthalmology, 2012
- Iron homeostasis and eye diseaseBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Recombinant human erythropoietin therapy in low‐birthweight preterm infants: A prospective controlled studyPediatrics International, 2005
- Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurityThrombosis and Haemostasis, 2005
- Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase‐mediated pathwaysBritish Journal of Pharmacology, 2003
- Effects of Early Erythropoietin Therapy on the Transfusion Requirements of Preterm Infants Below 1250 Grams Birth Weight: A Multicenter, Randomized, Controlled TrialPEDIATRICS, 2001
- Blood transfusion increases radical promoting non-transferrin bound iron in preterm infantsArchives of Disease in Childhood: Fetal & Neonatal, 2001
- Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusionsThe Journal of Pediatrics, 1996